Lifetime Cost-Utility Analysis of Patients with Refractory Epilepsy Treated with Adjunctive Topiramate Therapy: Cost-Effectiveness in Refractory Epilepsy

Author: Maltoni S.   Messori A.  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.23, Iss.4, 2003-01, pp. : 225-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract